Cargando…
Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: A case–control study
The aim of this study was to determine whether combined utilization of untimed single urine monocyte chemoattractant protein 1 (uMCP-1) and tumor necrosis factor (TNF)-like weak inducer of apoptosis (uTWEAK) could serve as a screening test for proteinuria in patients with lupus nephritis (LN). A cas...
Autores principales: | Dong, Xiwen, Zheng, Zhaohui, Luo, Xing, Ding, Jin, Li, Ying, Li, Zhiqin, Li, Sijia, Rong, Mengyao, Fu, Yalu, Wu, Zhenbiao, Zhu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916697/ https://www.ncbi.nlm.nih.gov/pubmed/29668584 http://dx.doi.org/10.1097/MD.0000000000010343 |
Ejemplares similares
-
Monocyte chemoattractant protein-1 (MCP-1)-2518 A/G polymorphism and lupus nephritis risk: A PRISMA-compliant meta-analysis
por: Sang, Guo-Yao, et al.
Publicado: (2017) -
The value of repeat biopsy in lupus nephritis flares
por: Narváez, Javier, et al.
Publicado: (2017) -
Clinical and Laboratory Predictors of Distinct Histopathogical Features of Lupus Nephritis
por: Mavragani, Clio P., et al.
Publicado: (2015) -
Silica-associated systemic lupus erythematosus with lupus nephritis and lupus pneumonitis: A case report and a systematic review of the literature
por: Fukushima, Kazuhiko, et al.
Publicado: (2022) -
Treatment of exostosin 1-associated membranous lupus nephritis with multiple low doses of rituximab: A case report
por: Li, Ling, et al.
Publicado: (2021)